Education
About Us
Working with TipRanks
Follow Us
Verve Therapeutics (VERV)
NASDAQ:VERV
Verve Therapeutics (VERV) Ownership Overview
15.35% Insiders
12.27% Mutual Funds
44.79% Other Institutional Investors
11.95% ETFs
15.64% Public Companies and
Individual Investors
The ownership structure of Verve Therapeutics (VERV) stock is a mix of institutional, retail, and individual investors. Approximately 69.01% of the company’s stock is owned by Institutional Investors, 15.35% is owned by Insiders, and 15.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 15, 2024 | Andrew Ashe President, Coo And Gc | xxxxxxxxxxxxx | $475760 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $227968 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,168,489 | Insider | 13.70% | 72,645,879 | |
| 3,739,725 | Institution | 4.21% | 22,326,158 | |
| 3,721,977 | Institution | 4.19% | 22,220,203 | |
| 3,150,281 | Institution | 3.55% | 18,807,178 | |
| 2,936,063 | Institution | 3.31% | 17,528,296 | |
| 1,691,530 | Institution | 1.90% | 10,098,434 | |
| 1,650,305 | Institution | 1.86% | 9,852,321 | |
| 1,607,982 | Institution | 1.81% | 9,599,653 | |
| 1,175,491 | Institution | 1.32% | 7,017,681 | |
| 805,625 | Institution | 0.91% | 4,809,581 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,150,281 | Institution | 3.55% | 18,807,178 | |
| 1,607,982 | Institution | 1.81% | 9,599,653 | |
| 1,175,491 | Institution | 1.32% | 7,017,681 | |
| 805,625 | Institution | 0.91% | 4,809,581 | |
| 644,323 | Institution | 0.73% | 3,846,608 | |
| 593,521 | Institution | 0.67% | 3,543,320 | |
| 438,931 | Institution | 0.49% | 2,620,418 | |
| 386,914 | Institution | 0.44% | 2,309,877 | |
| 342,594 | Institution | 0.39% | 2,045,286 | |
| 324,666 | Institution | 0.37% | 1,938,256 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,130,793 | Institution | 2.40% | 13,487,920 | |
| 1,901,516 | Institution | 2.14% | 11,352,051 | |
| 1,425,148 | Institution | 1.60% | 8,764,660 | |
| 1,021,821 | Institution | 1.15% | 6,468,127 | |
| 659,029 | Institution | 0.74% | 3,934,403 | |
| 383,363 | Institution | 0.43% | 2,288,677 | |
| 325,082 | Institution | 0.37% | 2,057,769 | |
| 319,606 | Institution | 0.36% | 1,965,577 | |
| 202,007 | Institution | 0.23% | 1,278,704 | |
| 160,271 | Institution | 0.18% | 956,818 |
FAQ
Who Owns Verve Therapeutics (VERV)?
According to the latest TipRanks data, approximately 44.79% of the company's stock is held by institutional investors, 15.35% is held by insiders, and 15.64% is held by retail investors.
What percentage of Verve Therapeutics (VERV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.79% of Verve Therapeutics (VERV) stock is held by institutional investors.
What percentage of Verve Therapeutics (VERV) stock is held by retail investors?
According to the latest TipRanks data, approximately 15.64% of Verve Therapeutics (VERV) stock is held by retail investors.
Who owns the most shares of Verve Therapeutics (VERV)?
Krishna Yeshwant owns the most shares of Verve Therapeutics (VERV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.